Dunhill Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9K Buy
122
+13
+12% +$6.24K 0.01% 299
2026
Q1
$54.3K Sell
109
-663
-86% -$360K 0.01% 302
2025
Q4
$53.2K Buy
772
+673
+680% +$381K 0.01% 266
2025
Q3
$48.1K Sell
99
-42
-30% -$19.5K 0.01% 266
2025
Q2
$57.4K Buy
141
+57
+68% +$23.8K 0.02% 225
2025
Q1
$41.7K Sell
84
-36
-30% -$19.5K 0.02% 206
2024
Q4
$62.5K Sell
120
-413
-77% -$227K 0.03% 167
2024
Q3
$330K Buy
533
+42
+9% +$24.9K 0.17% 51
2024
Q2
$272K Buy
491
+423
+622% +$242K 0.17% 56
2024
Q1
$39.3K Buy
68
+6
+10% +$3.37K 0.03% 127
2023
Q4
$33K Buy
+62
New +$30K 0.03% 124

Other funds holding TMO

Dunhill Financial's TMO Position: Q2 2026 in Review

Dunhill Financial increased its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, buying an estimated $6.24K and bringing the position to 122 shares worth $61.9K. The position accounts for 0.01% of the portfolio, ranked #299.

Dunhill Financial first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $330K in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Dunhill Financial held 122 shares of Thermo Fisher Scientific worth $61.9K as of Q2 2026.
  • Dunhill Financial bought 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
  • Thermo Fisher Scientific made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #299 holding.
  • Dunhill Financial first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Dunhill Financial's Thermo Fisher Scientific position peaked at $330K in Q3 2024.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.